Table of Content

1 Guselkumab Injection Market Overview
1.1 Product Overview and Scope of Guselkumab Injection
1.2 Guselkumab Injection Segment by Type
1.2.1 Global Guselkumab Injection Market Value Comparison by Type (2024-2034)
1.2.2 100mg Type
1.2.3 Other
1.3 Guselkumab Injection Segment by Application
1.3.1 Global Guselkumab Injection Market Value by Application: (2024-2034)
1.3.2 Plaque Psoriasis
1.3.3 Other
1.4 Global Guselkumab Injection Market Size Estimates and Forecasts
1.4.1 Global Guselkumab Injection Revenue 2018-2034
1.4.2 Global Guselkumab Injection Sales 2018-2034
1.4.3 Global Guselkumab Injection Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Guselkumab Injection Market Competition by Manufacturers
2.1 Global Guselkumab Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Guselkumab Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Guselkumab Injection Average Price by Manufacturers (2018-2023)
2.4 Global Guselkumab Injection Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Guselkumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Guselkumab Injection, Product Type & Application
2.7 Guselkumab Injection Market Competitive Situation and Trends
2.7.1 Guselkumab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Guselkumab Injection Players Market Share by Revenue
2.7.3 Global Guselkumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Guselkumab Injection Retrospective Market Scenario by Region
3.1 Global Guselkumab Injection Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Guselkumab Injection Global Guselkumab Injection Sales by Region: 2018-2034
3.2.1 Global Guselkumab Injection Sales by Region: 2018-2023
3.2.2 Global Guselkumab Injection Sales by Region: 2024-2034
3.3 Global Guselkumab Injection Global Guselkumab Injection Revenue by Region: 2018-2034
3.3.1 Global Guselkumab Injection Revenue by Region: 2018-2023
3.3.2 Global Guselkumab Injection Revenue by Region: 2024-2034
3.4 North America Guselkumab Injection Market Facts & Figures by Country
3.4.1 North America Guselkumab Injection Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Guselkumab Injection Sales by Country (2018-2034)
3.4.3 North America Guselkumab Injection Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Guselkumab Injection Market Facts & Figures by Country
3.5.1 Europe Guselkumab Injection Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Guselkumab Injection Sales by Country (2018-2034)
3.5.3 Europe Guselkumab Injection Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Guselkumab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Guselkumab Injection Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Guselkumab Injection Sales by Country (2018-2034)
3.6.3 Asia Pacific Guselkumab Injection Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Guselkumab Injection Market Facts & Figures by Country
3.7.1 Latin America Guselkumab Injection Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Guselkumab Injection Sales by Country (2018-2034)
3.7.3 Latin America Guselkumab Injection Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Guselkumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Guselkumab Injection Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Guselkumab Injection Sales by Country (2018-2034)
3.8.3 Middle East and Africa Guselkumab Injection Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Guselkumab Injection Sales by Type (2018-2034)
4.1.1 Global Guselkumab Injection Sales by Type (2018-2023)
4.1.2 Global Guselkumab Injection Sales by Type (2024-2034)
4.1.3 Global Guselkumab Injection Sales Market Share by Type (2018-2034)
4.2 Global Guselkumab Injection Revenue by Type (2018-2034)
4.2.1 Global Guselkumab Injection Revenue by Type (2018-2023)
4.2.2 Global Guselkumab Injection Revenue by Type (2024-2034)
4.2.3 Global Guselkumab Injection Revenue Market Share by Type (2018-2034)
4.3 Global Guselkumab Injection Price by Type (2018-2034)
5 Segment by Application
5.1 Global Guselkumab Injection Sales by Application (2018-2034)
5.1.1 Global Guselkumab Injection Sales by Application (2018-2023)
5.1.2 Global Guselkumab Injection Sales by Application (2024-2034)
5.1.3 Global Guselkumab Injection Sales Market Share by Application (2018-2034)
5.2 Global Guselkumab Injection Revenue by Application (2018-2034)
5.2.1 Global Guselkumab Injection Revenue by Application (2018-2023)
5.2.2 Global Guselkumab Injection Revenue by Application (2024-2034)
5.2.3 Global Guselkumab Injection Revenue Market Share by Application (2018-2034)
5.3 Global Guselkumab Injection Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Janssen Biotech
6.1.1 Janssen Biotech Corporation Information
6.1.2 Janssen Biotech Description and Business Overview
6.1.3 Janssen Biotech Guselkumab Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Janssen Biotech Guselkumab Injection Product Portfolio
6.1.5 Janssen Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Guselkumab Injection Industry Chain Analysis
7.2 Guselkumab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Guselkumab Injection Production Mode & Process
7.4 Guselkumab Injection Sales and Marketing
7.4.1 Guselkumab Injection Sales Channels
7.4.2 Guselkumab Injection Distributors
7.5 Guselkumab Injection Customers
8 Guselkumab Injection Market Dynamics
8.1 Guselkumab Injection Industry Trends
8.2 Guselkumab Injection Market Drivers
8.3 Guselkumab Injection Market Challenges
8.4 Guselkumab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Guselkumab Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Guselkumab Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Guselkumab Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Guselkumab Injection Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Guselkumab Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Guselkumab Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Guselkumab Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Guselkumab Injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Guselkumab Injection, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Guselkumab Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Guselkumab Injection, Product Type & Application
Table 12. Global Key Manufacturers of Guselkumab Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Guselkumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guselkumab Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Guselkumab Injection Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Guselkumab Injection Sales by Region (2018-2023) & (K Units)
Table 18. Global Guselkumab Injection Sales Market Share by Region (2018-2023)
Table 19. Global Guselkumab Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global Guselkumab Injection Sales Market Share by Region (2024-2034)
Table 21. Global Guselkumab Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Guselkumab Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Guselkumab Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Guselkumab Injection Revenue Market Share by Region (2024-2034)
Table 25. North America Guselkumab Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 27. North America Guselkumab Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America Guselkumab Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Guselkumab Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Guselkumab Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 32. Europe Guselkumab Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe Guselkumab Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Guselkumab Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Guselkumab Injection Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Guselkumab Injection Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Guselkumab Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Guselkumab Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Guselkumab Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Guselkumab Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Guselkumab Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Guselkumab Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Guselkumab Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Guselkumab Injection Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Guselkumab Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Guselkumab Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Guselkumab Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Guselkumab Injection Sales (K Units) by Type (2018-2023)
Table 51. Global Guselkumab Injection Sales (K Units) by Type (2024-2034)
Table 52. Global Guselkumab Injection Sales Market Share by Type (2018-2023)
Table 53. Global Guselkumab Injection Sales Market Share by Type (2024-2034)
Table 54. Global Guselkumab Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Guselkumab Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Guselkumab Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Guselkumab Injection Revenue Market Share by Type (2024-2034)
Table 58. Global Guselkumab Injection Price (US$/Unit) by Type (2018-2023)
Table 59. Global Guselkumab Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global Guselkumab Injection Sales (K Units) by Application (2018-2023)
Table 61. Global Guselkumab Injection Sales (K Units) by Application (2024-2034)
Table 62. Global Guselkumab Injection Sales Market Share by Application (2018-2023)
Table 63. Global Guselkumab Injection Sales Market Share by Application (2024-2034)
Table 64. Global Guselkumab Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Guselkumab Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Guselkumab Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Guselkumab Injection Revenue Market Share by Application (2024-2034)
Table 68. Global Guselkumab Injection Price (US$/Unit) by Application (2018-2023)
Table 69. Global Guselkumab Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Janssen Biotech Corporation Information
Table 71. Janssen Biotech Description and Business Overview
Table 72. Janssen Biotech Guselkumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Janssen Biotech Guselkumab Injection Product
Table 74. Janssen Biotech Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Guselkumab Injection Distributors List
Table 78. Guselkumab Injection Customers List
Table 79. Guselkumab Injection Market Trends
Table 80. Guselkumab Injection Market Drivers
Table 81. Guselkumab Injection Market Challenges
Table 82. Guselkumab Injection Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Guselkumab Injection
Figure 2. Global Guselkumab Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Guselkumab Injection Market Share by Type in 2024 & 2034
Figure 4. 100mg Type Product Picture
Figure 5. Other Product Picture
Figure 6. Global Guselkumab Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Guselkumab Injection Market Share by Application in 2024 & 2034
Figure 8. Plaque Psoriasis
Figure 9. Other
Figure 10. Global Guselkumab Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Guselkumab Injection Market Size (2018-2034) & (US$ Million)
Figure 12. Global Guselkumab Injection Sales (2018-2034) & (K Units)
Figure 13. Global Guselkumab Injection Average Price (US$/Unit) & (2018-2034)
Figure 14. Guselkumab Injection Report Years Considered
Figure 15. Guselkumab Injection Sales Share by Manufacturers in 2024
Figure 16. Global Guselkumab Injection Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Guselkumab Injection Players: Market Share by Revenue in 2024
Figure 18. Guselkumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Guselkumab Injection Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Guselkumab Injection Sales Market Share by Country (2018-2034)
Figure 21. North America Guselkumab Injection Revenue Market Share by Country (2018-2034)
Figure 22. U.S. Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Guselkumab Injection Sales Market Share by Country (2018-2034)
Figure 25. Europe Guselkumab Injection Revenue Market Share by Country (2018-2034)
Figure 26. Germany Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Guselkumab Injection Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Guselkumab Injection Revenue Market Share by Region (2018-2034)
Figure 33. China Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Guselkumab Injection Sales Market Share by Country (2018-2034)
Figure 44. Latin America Guselkumab Injection Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Guselkumab Injection Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Guselkumab Injection Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. U.A.E Guselkumab Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Guselkumab Injection by Type (2018-2034)
Figure 54. Global Revenue Market Share of Guselkumab Injection by Type (2018-2034)
Figure 55. Global Guselkumab Injection Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Guselkumab Injection by Application (2018-2034)
Figure 57. Global Revenue Market Share of Guselkumab Injection by Application (2018-2034)
Figure 58. Global Guselkumab Injection Price (US$/Unit) by Application (2018-2034)
Figure 59. Guselkumab Injection Value Chain
Figure 60. Guselkumab Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed